Recombinant Rat AGXT Protein
Cat.No. : | AGXT-569R |
Product Overview : | Recombinant Rat AGXT full length or partial length protein was expressed. |
- Specification
- Gene Information
- Related Products
Source : | Mammalian Cells |
Species : | Rat |
Tag : | His |
Form : | Liquid or lyophilized powder |
Endotoxin : | < 1.0 EU per μg of the protein as determined by the LAL method. |
Purity : | >80% |
Notes : | This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications. |
Storage : | Store it at +4 ºC for short term. For long term storage, store it at -20 ºC~-80 ºC. |
Storage Buffer : | PBS buffer |
Gene Name : | Agxt alanine-glyoxylate aminotransferase [ Rattus norvegicus ] |
Official Symbol : | AGXT |
Gene ID : | 24792 |
mRNA Refseq : | NM_030656.2 |
Protein Refseq : | NP_085914.2 |
MIM : | |
UniProt ID : | P09139 |
Products Types
◆ Recombinant Protein | ||
AGXT-314M | Recombinant Mouse AGXT Protein (25-414 aa), His-SUMO-tagged | +Inquiry |
Agxt-505R | Recombinant Rat Agxt Protein, His-tagged | +Inquiry |
AGXT-1322M | Recombinant Mouse AGXT Protein (25-414 aa), His-tagged | +Inquiry |
AGXT-225R | Recombinant Rat AGXT Protein, His (Fc)-Avi-tagged | +Inquiry |
Agxt-555M | Recombinant Mouse Agxt Protein, MYC/DDK-tagged | +Inquiry |
◆ Lysates | ||
AGXT-8967HCL | Recombinant Human AGXT 293 Cell Lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (10)
Ask a questionAGXT contains a PLP-binding domain, characteristic of aminotransferases, which is critical for its enzymatic activity and substrate specificity.
Yes, mutations in the AGXT gene can cause primary hyperoxaluria type 1 (PH1), a rare autosomal recessive disorder characterized by the overproduction and accumulation of oxalate, resulting in severe kidney and urinary tract complications.
Targeting AGXT enzymatic activity may hold promise for developing therapies to prevent kidney stone formation in non-PH1 patients; however, further research is needed to validate this approach.
AGXT is primarily localized in the peroxisomes, a subcellular organelle responsible for various metabolic processes, including lipid metabolism and detoxification.
Epigenetic modifications, such as DNA methylation or histone acetylation, could potentially regulate AGXT gene expression and activity, affecting oxalate metabolism.
AGXT activity can be regulated by phosphorylation, allosteric modulation, and interaction with other proteins involved in peroxisomal metabolism.
AGXT plays a crucial role in the peroxisomal glyoxylate pathway, converting glyoxylate to glycine to prevent the accumulation of harmful oxalate, which can lead to kidney stone formation.
In PH1 patients, AGXT deficiency impairs the conversion of glyoxylate to glycine, leading to the accumulation of glyoxylate. Excessive glyoxylate is converted to oxalate, which can form kidney stones and cause tissue damage.
AGXT may participate in other cellular processes or metabolic pathways, and its broader functional roles warrant further exploration.
AGXT catalyzes the conversion of glyoxylate and L-alanine to glycine and pyruvate, utilizing PLP as a cofactor.
Customer Reviews (5)
Write a reviewThe customer service was fantastic—helpful, friendly, and made the ordering process a breeze!
The efficiency of this protein is outstanding. Saved me a lot of time!
I never knew how much easier my work could be until I tried this protein.
I'm so grateful for this protein – it's a game-changer for my studies!
I can confidently say that this product is worth every penny.
Ask a Question for All AGXT Products
Required fields are marked with *
My Review for All AGXT Products
Required fields are marked with *
Inquiry Basket